カプセル内視鏡の世界市場 - 予測（2022年～2027年）

世界のカプセル内視鏡の市場規模は、2020年は8億8,324万4,000米ドルで、予測期間中に6.04％のCAGRで成長し、2027年には13億3,179万5,000米ドルに達すると予測されています。市場の成長を後押しする主な要因には、政府の支持的なイニシアチブ、より速く、より正確な診断の需要の増加、腸の障害や消化器疾患の発生率の増加、高齢者人口の増加などが挙げられます。一方で、カプセル内視鏡検査のリスクや合併症、熟練した医師の不足などが課題となっています。

当レポートでは、世界のカプセル内視鏡市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、コンポーネント別・内視鏡タイプ別・製品別・用途別・エンドユーザー別・地域別の分析、および競合情勢などを提供しています。

目次

第1章 イントロダクション

• 市場概要
• COVID-19シナリオ
• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • エンドユーザーの交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 業界での競争企業間の敵対関係
• 業界バリューチェーン分析

第5章 カプセル内視鏡市場：コンポーネント別

• イントロダクション
• カプセル内視鏡
• カプセル内視鏡データレコーダー
• カプセル内視鏡ワークステーション

第6章 カプセル内視鏡市場：内視鏡タイプ別

• イントロダクション
• カプセル膀胱鏡
• カプセル神経内視鏡

第7章 カプセル内視鏡市場：製品別

• イントロダクション
• 小腸
• 食道
• 大腸

第8章 カプセル内視鏡市場：用途別

• イントロダクション
• OGIB
• クローン病
• 腸の疾患
• その他

第9章 カプセル内視鏡市場：エンドユーザー別

• イントロダクション
• 病院
• 診療所
• その他

第10章 カプセル内視鏡市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • その他
• アジア太平洋
  • 中国
  • 日本
  • 韓国
  • インド
  • インドネシア
  • タイ
  • 台湾
  • その他

第11章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の収益性
• 合併、買収、契約、およびコラボレーション
• ベンダーの競争力マトリックス

第12章 企業プロファイル

• JInshan Science & Technology
• IntroMedic Co. Ltd.
• Olympus America Inc.
• CapsoVision Inc.
• Medtronic Plc.
• FujiFilm Corporation
• RF Co. Ltd.
• Boston Scientific Corporation
• Steris Corporation

The capsule endoscopy market was valued at US$883.244 million in 2020 and is expected to grow at a CAGR of 6.04% over the forecast period to reach a market size of US$1,331.795 million in 2027.

A capsule endoscopy camera is like a vitamin-size capsule that is swallowed by people. The procedure of Capsule Endoscopy is done with the use of a tiny wireless camera that takes images of the digestive tract. The capsule contains video chips, a light bulb, a battery, and a radio transmitter. It takes thousands of images as it travels through our digestive tract; and sends them through the transmitter. These images are used by the doctor to see areas that cannot be reached easily with traditional endoscopy procedures. The main use of the capsule is to diagnose gastrointestinal complications, inflammatory bowel diseases, celiac diseases, polyps screening, oesophagus examination, and abnormal tissue growth where the traditional endoscopy is ineffective and helps in at-time and faster recovery. The growth of the capsule endoscopy market is substantiated by supportive government initiatives, increasing demand for faster and more accurate diagnostics, growing incidences of intestinal disorders and gastrointestinal diseases, and the increasing geriatric population. However, the risks and complications of capsule endoscopy and the lack of skilled physicians remain major challenges.

Drivers

The rising geriatric population base is projected to provide the capsule endoscopy market with a strong platform for growth over the analyzed period. Aging significantly increases the risk of gastrointestinal disorders like inflammatory bowel disease, Crohn's disease, colorectal cancer, and appendicitis, to name a few. Further, the growing prevalence of cancer in older as well as younger adults in recent times and the increasing adoption of screening tests, including capsule endoscopy for detection is likely to propel market growth. According to the statistics provided by the American Cancer Society, it is projected that about 1.9 million cancer cases would be reported in the US by the end of 2022. Such an increasing prevalence is thus expected to catalyze the growth of the market.

Further, the growing adoption of minimally invasive surgical interventions has accelerated the utilization of capsule endoscopic systems and wireless capsules, majorly for the detection or diagnosis of gastrointestinal issues such as OGIB (obscure gastrointestinal tract bleeding), Crohn's disease, cancer, and small intestine tumor. Capsule endoscopy provides efficient and rapid results concerning screening of such conditions, thereby boosting the adoption of this method and leading to market growth.

Adding to that, strategic alliances among market players, such as mergers, acquisitions, and partnerships, along with growing R&D in the area of capsule-based endoscopic technologies are some of the factors that are further expected to drive the growth of the market. for instance, in 2020, Medtronic announced a partnership with Amazon for the home delivery of its capsule endoscope, PillCam Genius. Through this partnership, it aimed at increasing its penetration at a global scale and enhancing patient comfort and satisfaction.

Application Insights

Based on application, the OGIB segment is expected to hold dominant shares in the market, due to the numerous advantages provided by capsule endoscopy in the diagnosis and detection of OGIB. Additionally, benefits like real-time visualization, image capturing, and analysis of the entire small intestine, along with reliable and precise results attribute to the increase in the adoption of capsule endoscopes for OGIB. Further, the shift in trend towards the adoption of capsule-based endoscopy screening for OGIB as compared to the other conventional methods, such as double-balloon enteroscopy, is further expected to aid in the growth of the segment.

Moreover, the Crohn's disease segment is projected to grow at a substantial rate during the analyzed period due to the increasing utilization of capsule endoscopes for the detection of Crohn's disease. It is considered one of the most common types of Inflammatory Bowel Disease (IBD) and the rising prevalence of IBD, along with Crohn's disease is likely to augment market growth during the forecasted period. Canada has one of the highest incidence rates of IBD, including Crohn's disease and ulcerative colitis. For instance, according to 2021 statistics provided by Crohn's and Colitis Canada, around 260,000 people in the country were found to be living with IBD which is a substantially high number. In addition, the IBD prevalence rate is anticipated to increase by 50% by the year 2030, with around 400,000 Canadians getting diagnosed with IBD, according to a study by Crohn's and Colitis Canada in 2018.

COVID-19 insights

The outbreak of the COVID-19 pandemic had a mixed impact on the capsule endoscopy market. The delay, cancellation, and reduction in the number of elective surgeries performed during the initial phases of the pandemic significantly impacted the market. Further, changing regulations with regard to surgical interventions and endoscopic screening procedures, and imbalance in the supply chain were some of the key factors that hindered the growth of the market for capsule endoscopy during the pandemic.

Furthermore, capsule endoscopy training for medical professionals was also impacted severely. Several institutions opted for e-learning modules for training. However, the advantages provided by capsule endoscopy boosted the growth of the market post the initial phases of the pandemic. For instance, according to a 2021 cohort study of 146 patients (out of which 74 were COVID-19 positives) published by JAMA Network, active bleeding was identified more frequently using video capsule endoscopy as the first strategy, at about 59.5%, as compared to the traditional detection process. Hence, such instances provided growth to the market and are expected to accelerate the growth even further now that the condition has gotten better.

Market Segmentation:

By Component

Capsule Endoscopy

Capsule Endoscopy Data Recorder

Capsule Endoscopy Workstations

By Endoscope Type

Cystoscopies

Neuro-Endoscopes

By Product

Small Bowel Capsule

Esophageal Capsule

Colon Capsule

By Application

Obscure Gastrointestinal Bleeding

Crohn's Disease

Intestine Disease

Others

By End-User

Hospitals

Clinics

Others

By Geography

North America

USA

Canada

Mexico

South America

Brazil

Argentina

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Others

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

Asia Pacific

China

Japan

South Korea

India

Indonesia

Thailand

Taiwan

Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Covid-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of End-Users
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CAPSULE ENDOSCOPY MARKET BY COMPONENT

• 5.1. Introduction
• 5.2. Capsule Endoscopy
• 5.3. Capsule Endoscopy Data Recorder
• 5.4. Capsule Endoscopy Workstations

6. CAPSULE ENDOSCOPY MARKET BY ENDOSCOPE TYPE

• 6.1. Introduction
• 6.2. Cystoscopies
• 6.3. Neuro-Endoscopes

7. CAPSULE ENDOSCOPY MARKET By Product

• 7.1. Introduction
• 7.2. Small Bowel Capsule
• 7.3. Esophageal Capsule
• 7.4. Colon Capsule

8. CAPSULE ENDOSCOPY MARKET By Application

• 8.1. Introduction
• 8.2. Obscure Gastrointestinal Bleeding
• 8.3. Crohn's Disease
• 8.4. Intestine Disease
• 8.5. Others

9. CAPSULE ENDOSCOPY MARKET BY END-USER

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Clinics
• 9.4. Others

10. CAPSULE ENDOSCOPY MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. United States
  • 10.2.2. Canada
  • 10.2.3. Mexico
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Others
• 10.4. Europe
  • 10.4.1. UK
  • 10.4.2. Germany
  • 10.4.3. France
  • 10.4.4. Italy
  • 10.4.5. Spain
  • 10.4.6. Others
• 10.5. Middle East and Africa (MEA)
  • 10.5.1. Saudi Arabia
  • 10.5.2. UAE
  • 10.5.3. Israel
  • 10.5.4. Others
• 10.6. Asia Pacific
  • 10.6.1. China
  • 10.6.2. Japan
  • 10.6.3. South Korea
  • 10.6.4. India
  • 10.6.5. Indonesia
  • 10.6.6. Thailand
  • 10.6.7. Taiwan
  • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Emerging Players and Market Lucrativeness
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Vendor Competitiveness Matrix

12. COMPANY PROFILES

• 12.1. JInshan Science & Technology
• 12.2. IntroMedic Co. Ltd.
• 12.3. Olympus America Inc.
• 12.4. CapsoVision Inc.
• 12.5. Medtronic Plc.
• 12.6. FujiFilm Corporation
• 12.7. RF Co. Ltd.
• 12.8. Boston Scientific Corporation
• 12.9. Steris Corporation